DURECT Corporation (DRRX)

1,1600 +0,1700 (+17,17%) Börsenschluss: 04:00PM EDT

DURECT Corporation

10240 Bubb Road
Cupertino, CA 95014-4166
United States
408 777 1417
https://www.durect.com

Sektor(en): Healthcare
Branche: Drug Manufacturers - Specialty & Generic
Vollzeitmitarbeiter: 58

Leitende Angestellte

Name	Titel	Zahlen	Ausgeübt	Geburtsjahr
Dr. James E. Brown D.V.M.	Co-Founder, CEO, President & Director	633,46k	N/A	1957
Mr. Timothy M. Papp M.B.A.	CFO & Secretary	427,62k	N/A	1976
Dr. Norman L. Sussman M.D.	Chief Medical Officer	471,71k	N/A	1953
Ms. Judy R. Joice	Senior Vice President of Operations & Corporate Quality Assurance	451,82k	N/A	1957
Dr. WeiQi Lin M.D., Ph.D.	Executive VP of Research & Development and Principal Scientist	N/A	N/A	N/A
Mr. Keith L. Lui M.B.A.	Senior Vice President of Business Development, Commercial & Medical Affairs	N/A	N/A	N/A
Ms. Jian Li M.B.A.	Senior VP of Finance, Corporate Controller & Secretary	297,08k	16,41k	1970
Dr. Su Il Yum Ph.D.	Executive Officer	331,74k	62,44k	1939

Die Beträge haben den Stand 31. Dezember 2023 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in USD.

Beschreibung

DURECT Corporation, a biopharmaceutical company, develops medicines based on its epigenetic regulator program. The company's lead product larsucosterol (DUR-928), an endogenous, orally bioavailable small molecule that is in Phase IIb clinical trial to play a regulatory role in lipid metabolism, stress and inflammatory responses, and cell death and survival to treat alcohol-associated hepatitis, as well as completed Phase Ib clinical trial to treat patients with nonalcoholic steatohepatitis. It also offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. In addition, the company offers POSIMIR, a post-surgical pain product to deliver bupivacaine over three days in adults; and Methydur to treat attention deficit hyperactivity disorder. It markets and sells its ALZET lines through direct sales force in the United States, as well as through a network of distributors in other countries. The company has strategic collaboration and other agreements with Virginia Commonwealth University Intellectual Property Foundation; Indivior UK Ltd.; and Innocoll Pharmaceuticals Limited. DURECT Corporation was incorporated in 1998 and is headquartered in Cupertino, California.

Corporate Governance

DURECT Corporations ISS Governance QualityScore, Stand 1. Mai 2024, lautet 6. Die grundlegenden Scores sind Audit: 9, Vorstand: 2, Shareholderrechte: 7, Kompensation: 5.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.